Key result
Shortened versions of the Manual Muscle Test-8 (MMT-4 and MMT-6) demonstrated good internal consistency (0.88–0.96) and strong ability to discriminate between disease activity states (P<0.001).
Why the study?
To develop and test shortened versions of the Manual Muscle Test-8 (MMT-8) in juvenile dermatomyositis.
Observational
Yes
The reduced 4- and 6-muscle versions of the MMT-8 demonstrate comparable metrologic performance to established tools, offering a more efficient option for assessing muscle strength in juvenile dermatomyositis.
Answers are grounded in this paper and cite their sources.
Shortened MMT versions may streamline juvenile dermatomyositis assessments; leaves open prospective validation before practice change.
Objective. To develop and test shortened versions of the Manual Muscle Test-8 (MMT-8) in juvenile dermatomyositis (JDM). Methods. Construction of reduced tools was based on a retrospective analysis of individual scores of MMT-8 muscle groups in 3 multinational datasets. The 4 and 6 most frequently impaired muscle groups were included in MMT-4 and MMT-6, respectively. Metrologic properties of reduced tools were assessed by evaluating construct validity, internal consistency, discriminant ability, and responsiveness to change. Results. Neck flexors, hip extensors, hip abductors, and shoulder abductors were included in MMT-4, whereas MMT-6 also included elbow flexors and hip flexors. Both shortened tools revealed strong correlations with MMT-8 and other muscle strength measures. Correlations with other JDM outcome measures were in line with predictions. Internal consistency was good (0.88–0.96) for both MMT-4 and MMT-6. Both reduced tools showed strong ability to discriminate between disease activity states, assessed by the caring physician or a parent ( P < 0.001), and between patients whose parents were satisfied or not satisfied with illness course ( P < 0.001). Responsiveness to change (assessed by both standardized response mean and relative efficiency) of MMT-4 and, to a lesser degree, MMT-6, was slightly superior to that of MMT-8. Conclusion. Overall, the metrologic performance of MMT-4 and MMT-6 was comparable to that of the other established muscle strength tools, which indicates that they may be suitable for use in clinical practice and research, including clinical trials. The measurement properties of these tools should be further tested in other patient populations and evaluated prospectively.
No takes yet. Share an insight, caveat, or question.
Rosina et al. (2020) conducted an observational in Juvenile dermatomyositis. MMT-4 and MMT-6 (shortened versions of Manual Muscle Test-8) vs. MMT-8 was evaluated on Metrologic properties (construct validity, internal consistency, discriminant ability, and responsiveness to change) (p=<0.001). Shortened versions of the Manual Muscle Test-8 (MMT-4 and MMT-6) demonstrated good internal consistency (0.88–0.96) and strong ability to discriminate between disease activity states (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: